Facebook Linkedin RSS Twitter Youtube
Home 2024

Roche company

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic
Artificial Intelligence

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic

RNA Rewriting to Treat Neurological Disease Focus of Ascidian, Roche Collaboration
Drug Discovery

RNA Rewriting to Treat Neurological Disease Focus of Ascidian, Roche Collaboration

StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting
Drug Discovery

StockWatch: Regeneron Shares Dip as DOJ Alleges Fraudulent Price Reporting

Best of NGS: The Instrument Companies to Watch
A-Lists

Best of NGS: The Instrument Companies to Watch

Iambic Rhythm: AI Drug Developer Enters the Clinic, Targeting HER2 Cancers
Artificial Intelligence

Iambic Rhythm: AI Drug Developer Enters the Clinic, Targeting HER2 Cancers

SPT Labtech to Co-Market NGS Library Prep Workflows with Roche
News

SPT Labtech to Co-Market NGS Library Prep Workflows with Roche

Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B
Bioprocessing

Lonza to Buy Genentech’s Vacaville, CA Biologics Manufacturing Site for $1.2B

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate
Artificial Intelligence

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate

GenEdit Tackles “Delivery, Delivery, Delivery” with Up-to-$644M Genentech Collaboration
Drug Discovery

GenEdit Tackles “Delivery, Delivery, Delivery” with Up-to-$644M Genentech Collaboration

Top 25 Biotech Companies of 2024
A-Lists

Top 25 Biotech Companies of 2024

123...54Page 1 of 54
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.